Patents by Inventor William ESMIEU

William ESMIEU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12281116
    Abstract: Provided herein are certain compounds useful as HTT modulators. Such compound are useful in the treatment of Huntington's disease.
    Type: Grant
    Filed: November 16, 2022
    Date of Patent: April 22, 2025
    Assignee: CHDI Foundation, Inc.
    Inventors: Longbin Liu, Celia Dominguez, Nikolay V. Plotnikov, Alan Haughan, Andrew Stott, Brett Cosgrove, Cole Clissold, Huw Vater, Jonathan Spencer, William Esmieu, Karine Malagu, Mark Chambers
  • Publication number: 20230159531
    Abstract: Provided herein are certain compounds useful as HTT modulators. Such compound are useful in the treatment of Huntington's disease.
    Type: Application
    Filed: November 16, 2022
    Publication date: May 25, 2023
    Inventors: Longbin Liu, Celia Dominguez, Nikolay V. Plotnikov, Alan Haughan, Andrew Stott, Brett Cosgrove, Cole Clissold, Huw Vater, Jonathan Spencer, William Esmieu, Karine Malagu, Mark Chambers
  • Publication number: 20170143718
    Abstract: Compounds, compositions and methods for the treatment of retinal degenerative diseases, such as retinitis pigmentosa, Leber's congenital Amaurosis, Syndromic retinal degenerations, age-related macular degeneration and Usher Syndrome, and hearing loss associated with Usher Syndrome are described herein.
    Type: Application
    Filed: December 12, 2016
    Publication date: May 25, 2017
    Inventors: Roland Werner BÜRLI, William ESMIEU, Christopher James LOCK, Karine Fabienne MALAGU, Andrew Pate OWENS, William E. HARTE